Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-26-059167
Filing Date
2026-05-19
Accepted
2026-05-19 18:14:17
Documents
1
Period of Report
2026-05-13

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1686
  Complete submission text file 0001213900-26-059167.txt   3146
Mailing Address C/O SCYNEXIS, INC. 3501 C TRICENTER BOULEVARD DURHAM NC 27713
Business Address
Francois Eric (Reporting) CIK: 0001656125 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41719 | Film No.: 261000759

Mailing Address 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036
Business Address 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036 202-327-5422
60 DEGREES PHARMACEUTICALS, INC. (Issuer) CIK: 0001946563 (see all company filings)

EIN.: 452406880 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)